Cogent Biosciences(COGT)

12.90 0.30 2.381%

今开:12.32昨收:12.6
最高:13.0 最低:12.32
涨停价:0.0跌停价:0.0
总市值:9.01625299E8

Cogent Biosciences的热门评论

chuminhua06-11 11:42

6月10日,Cogent Biosciences 的股价上涨了 78%,此前该公司报告了强效、选择性 KIT D816V 抑制剂bezuclastinib用于晚期系统性肥大细胞增多症患者中治疗的 II 期试验的“积极”初步数据。
截至 5 月 24 日的数据截止日期,该开放标签试验已经在四个剂量水平中的1个治疗了 11 名患者。两名患者...查看全文

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的最新评论

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

$Cogent(COGT)$ 内部交易: 2017-01-20,Director,Swayman Robert ,买入,50000普通股, $3.12

$Cogent(COGT)$ 内部交易: 2017-01-23,总裁 of Fluent, LLC,Conlin Matthew ,买入,100000普通股, $3.15

$Cogent(COGT)$ 内部交易: 2017-01-23,CEO of Fluent, LLC,Schulke Ryan ,买入,150000普通股, $3.15

$Cogent(COGT)$ 内部交易: 2016-12-14,执行Chairman,Brauser Michael ,买入,1000普通股, $3.34

$Cogent(COGT)$ 内部交易: 2016-12-14,执行Chairman,Brauser Michael ,买入,500普通股, $3.20

$Cogent(COGT)$ 美东时间 2016-11-03 16:30 After Market Close:COGINT INC Earning Release . Wall St EPS Est ($):-0.11. 网页链接

$Cogent(COGT)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2010-10-27 AccNo: 0001104659-10-054045 Size: 122 KB 网页链接

$Cogent(COGT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2010-12-03 AccNo: 0001104659-10-061106 Size: 47 KB 网页链接

$Cogent(COGT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2010-10-27 AccNo: 0001104659-10-054045 Size: 122 KB 网页链接

$Cogent(COGT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2010-12-09 AccNo: 0001193125-10-277387 Size: 16 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20